- $694.24m
- $733.01m
- $502.73m
Oncology Institute surges on AI-driven cancer research deal
Brief: The Oncology Institute And Massive Bio Forge Partnership To Revolutionize Cancer Care And AI-Enabled Cancer Research
Brief: Oncology Institute Notifies COO Matthew Miller Of His Termination
Brief: Oncology Institute Sees 2023 Revenue Of $290 To $320 Million
Brief: Oncology Institute Q1 revenue USD 76 million
Brief: The Oncology Institute Reports First Quarter 2023 Financial Results And Reaffirms Full Year 2023 Guidance
Brief: Oncology Institute - On April 25, Co Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Corrected: BRIEF-(OFFICIAL)-Oncology Institute Q4 revenue USD 71 million (Mar.9)
Oncology Institute Inc reports results for the quarter ended in December - Earnings Summary
Brief: The Oncology Institute Reports Fourth Quarter And Full Year 2022 Financial Results
Brief: Oncology Institute Q4 revenue USD 71 million
Oncology Institute Inc expected to post a loss of 18 cents a share - Earnings Preview
Brief: Oncology Institute Rebrands Clinical Trials Division
Oncology Institute Inc reports results for the quarter ended in September - Earnings Summary
Brief: The Oncology Institute Reports Third Quarter 2022 Financial Results
Oncology Institute Inc expected to post a loss of 18 cents a share - Earnings Preview
Brief: The Oncology Institute Enrolls Nation’S First Two Patients In A Phase 3 Open-Label, Randomized Clinical Trial Of Pirtobrutinib
Brief: The Oncology Institute Appoints Two New Board Members
Brief: Oncology Institute Becomes Certified As Patient Safety Organization